New York Oncology Hematology P.C is a clinical research site located in Albany, New York, United States 12208.
Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.
New York Oncology Hematology P.C has participated in 89 clinical trials with 20 currently active.
Therapeutic areas: Urothelial Carcinoma, Ovarian Cancer, Fallopian Tube Cancer.
Sponsors: Genentech, Inc., Novartis Pharmaceuticals, Seagen, a wholly owned subsidiary of Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Albany
Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Oncology Hematology P.C has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Oncology Hematology P.C has 89 clinical trials on record, with 20 currently active. Their work covers Urothelial Carcinoma, Ovarian Cancer, Fallopian Tube Cancer.
New York Oncology Hematology P.C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.